CEO Replaces $500K RSU Award with Out-of-Money Options, Signaling Confidence Amidst Delisting
MEHA is trading near its 52-week low of $0.004 (1.5% above the low).
Summary
Functional Brands' CEO exchanged a $500,000 RSU award for immediately vested, out-of-the-money stock options, demonstrating strong confidence in the company's future despite delisting and low stock price.
Key Events · Executive and Board Changes · MEHA
-
CEO Compensation Restructured
CEO Eric Gripentrog's employment agreement was amended to replace a $500,000 restricted stock unit (RSU) award with a grant of options.
-
Out-of-the-Money Options Granted
The CEO received options to purchase 3,500,000 shares at an exercise price of $0.0055 per share, which is above the current market price of $0.0043.
-
Immediate Vesting
The granted options are fully vested and immediately exercisable, allowing the CEO to act on them without delay.
-
Significant Reduction in Immediate Value
The options have a grant-date fair value of approximately $14,685, a substantial decrease from the $500,000 RSU award they replaced, indicating a strong performance-based incentive.
Analysis · MEHA · Life Sciences
Functional Brands' CEO, Eric Gripentrog, has replaced a $500,000 restricted stock unit (RSU) award with options to purchase 3.5 million shares. These options have an exercise price of $0.0055, which is above the current stock price of $0.0043, and are fully vested immediately. This move, occurring while the company faces Nasdaq delisting and trades near 52-week lows, represents a significant reduction in immediate compensation value for the CEO (from $500k to an option fair value of $14.7k) and a strong personal bet on the company's future stock price appreciation. It signals high conviction from leadership in a challenging period.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEHA was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $183.8K. The 52-week trading range was $0.00 to $8.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.